Therapeutic Plasma Exchange Market - Global Industry Analysis

Therapeutic Plasma Exchange Market By Diseases Indication (Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders, And Others), By End-Users (Hospitals, Specialty Clinics, and Ambulatory Surgical Centers), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 – 2028

Published Date: 10-Aug-2022 Category: Healthcare Report Format : PDF Pages: 280 Report Code: ZMR-3785 Status : Published

The global therapeutic plasma exchange market size was worth USD 1,528.40 million in 2021 and is estimated to grow to USD 2306.60 million by 2028, with a compound annual growth rate (CAGR) of approximately 7.10 percent over the forecast period.

Description

Industry Perspective:

The global therapeutic plasma exchange market size was worth USD 1,528.40 million in 2021 and is estimated to grow to USD 2306.60 million by 2028, with a compound annual growth rate (CAGR) of approximately 7.10 percent over the forecast period. The report analyzes the therapeutic plasma exchange market's drivers, restraints/challenges, and their effect on the demands during the projection period. In addition, the report explores emerging opportunities in the therapeutic plasma exchange market.

Therapeutic Plasma Exchange Market: Overview

Therapeutic plasma exchange (TPE), also known as plasmapheresis, is an endovascular blood technique used to separate that means removing pathogenic substances from clients' blood and replacing them with replacement fluid such as albumin solution or frequently fresh frozen plasma. These compounds include infective autoantibodies, immune complexes, cryoglobulins, and cholesterol-containing lipoproteins. TPE is used to treat various autoimmune conditions, renal disorders, hematological disorders, etc., and is anticipated to fuel market expansion. Plasma viscosity can be significantly reduced by therapeutic plasma exchange (TPE). As a result, it can enhance blood flow and improve patient outcomes in COVID-19-positive critically ill patients. It is used as a first- or second-line therapy for a variety of chronic disorders in both neurology and non-neurological situations.

The main factors contributing to the market's growth are the rising number of clients with inflammatory illnesses, hematological disorders, cardiovascular diseases, and the elderly population. The prevalence of neurological health issues has significantly increased among the elderly. The use of cutting-edge techniques like plasma exchange in treating neurological illnesses is also becoming more widely known. These elements are anticipated to create fantastic demand opportunities in the global therapeutic plasma exchange market.

COVID-19 Impact:

The Covid-19 outbreak has impacted the growth expectations for several industries and companies. Coronavirus-infected patients have had success with convalescent plasma treatment. Biologics, convalescent plasma, and antivirals have all been utilized with varying degrees of success. Acute respiratory distress syndrome, sepsis, and multi-organ failure are brought on by the severe "cytokine storm" driven epitheliopathy and micro thrombotic illness in COVID-19 patients. The only method known to reduce plasma viscosity directly and swiftly is therapeutic plasma exchange (TPE), suggesting that TPE may improve patient outcomes in critically ill Covid-19 patients by reducing plasma viscosity and consequently boosting blood flow.

Global Therapeutic Plasma Exchange Market

Key Insights

  • As per the analysis shared by our research analyst, the global therapeutic plasma exchange market value to grow at a CAGR of 7.10% over the forecast period.
  • In terms of revenue, the global therapeutic plasma exchange market size was valued at around USD 1,528.40 million in 2021 and is projected to reach USD 2306.60 million, by 2028.
  • The government's favorable reimbursement policies will increase the number of patients with autoimmune diseases, and this, combined with an increase in healthcare facility consolidation, will fuel market expansion.
  • By end users, the hospitals category dominated the market in 2021.
  • By disease indication, the neurological disorder category dominated the market in 2021.
  • North America dominated the global therapeutic plasma exchange market in 2021.

Therapeutic Plasma Exchange Market: Growth Drivers

Therapeutic plasma exchange for pediatric patients to drive market growth

Therapeutic plasma exchange treatments are rarely used on pediatric patients. Although this therapeutic approach has several technical limitations in children, pediatric nephrology uses it more frequently. Market players may have opportunities for expansion due to the increased use of therapeutic plasma exchange to treat various disorders. Due to technological advancements, juvenile children with renal disorders undergo TPE operations, which has fueled the growth of the global therapeutic plasma exchange market.

Therapeutic Plasma Exchange Market: Restraints

High cost of for therapeutic plasma exchange products to hinder the market growth

The cost of equipment heavily influences the adoption of plasma exchange by medical professionals and, ultimately, patients. Blood banks employ apheresis equipment to collect blood components, and hospitals utilize it for therapeutic plasma exchange operations. The entire cost of apheresis treatments is also increased by the high cost of equipment and disposable items.

Therapeutic Plasma Exchange Market: Opportunity

Continuous advancement to present market growth opportunities

Constant advancement in technology has improved and become a high-precision method. It improves patient satisfaction and more effective processing of goods made from blood and plasma. Compared to other technologies, like membrane separation methods, this method needs a small amount of blood flow. It is a more advanced technique that simplifies getting blood through the patient's antecubital or radial veins. More precise hydration status control for greater hemodynamic stability during treatment and improved patient comfort and safety during the TPE operation are also outcomes of these technological advancements, generating profitable potential pockets in the market.

Therapeutic Plasma Exchange Market: Segmentation

The global therapeutic plasma exchange market has been segmented into end users, diseases indication, and region.

Based on end users, the market is classified into hospitals, specialty clinics, and ambulatory surgical centers. In 2021, the hospital's category dominated the global market. The segment is anticipated to increase at the fastest rate. The domination of the hospital sector is ascribed to an increase in autoimmune disorder sufferers and a growth in the number of patients using Medicare & other reimbursement systems. The hospital category is also driven by a surge in healthcare facility consolidation and an increase in doctors moving from private clinics to large-scale hospitals.

Based on disease indication, the global therapeutic plasma exchange market is segmented into neurological disorders, renal disorders, hematology disorders, and other disorders. The neurological disorder is anticipated to have the highest share in this market. The incidence and prevalence of neurological diseases are increasing in the geriatric population, knowledge & understanding of the use of plasma exchange in treating neurological diseases is rising, and key players are increasing their R&D expenditures on new applications for therapeutic plasma exchange in the management of neurological disorders. These factors are the main drivers of market growth.

Recent Developments

  • April 2020: Terumo BCT and Marker Therapeutics received the first FDA emergency use authorization (EUA) device to treat COVID-19 patients with acute respiratory failure.
  • May 2020 Ceros Corporation acquired FDA regulatory permission to manufacture INTERCEPT plasma using a novel, disposable plastic kit.
  • December 2019: Haemon tics Corporation launched its new corporate headquarters in Downtown Boston.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Therapeutic Plasma Exchange Market: Regional Landscape

North America dominated the therapeutic plasma exchange market in 2021

The dominance of North America in the global therapeutics plasma exchange market is brought on by a growth in the incidence of several autoimmune diseases global, a sharp increase in the use of lipoprotein apheresis therapy for cardiac diseases such as coronary artery disease (CAD), hypercholesterolemia strokes, and atherosclerosis, as well as a recent surge in the number of cardiac deaths. The demand for therapeutic plasma exchange treatments will be driven primarily by the high geriatric population and rising healthcare spending in this region over the next few years, which will undoubtedly accelerate the regional market expansion.

North America is anticipated to have the most revenue over the projected period due to established hospital infrastructure and top global companies. Their domination has been aided by the presence of numerous biotech enterprises, as well as academic and research institutions. The need for therapeutic plasma exchange treatments is also anticipated to increase over time due to the accelerated expansion of academic and research organizations in these fields.

Therapeutic Plasma Exchange Market: Competitive Landscape

Some of the main competitors dominating the global therapeutic plasma exchange market include- Asahi Kasei Corporation, Baxter International, Inc., Terumo Corporation, B. Braun Melungeon AG, Fresenius Kabir AG, Karasumi Laboratories, Inc., Haemon tics Corporation, Ceros Corporation, Hema care Corporation, and Medica S.p.A.

Global Therapeutic Plasma Exchange Market is segmented as follows:

By Diseases Indication

  • Neurological Disorders
  • Renal Disorders
  • Hematology Disorders

By End-Users

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France 
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1 Report Description and Scope
    • 1.2 Research scope
    • 1.3 Research methodology
      • 1.3.1 Market Research Type
      • 1.3.2 Market research methodology
  • Chapter 2. Executive Summary
    • 2.1 Global Therapeutic Plasma Exchange Market, (2022 - 2028) (USD Million)
    • 2.2 Global Therapeutic Plasma Exchange Market : snapshot
  • Chapter 3. Global Therapeutic Plasma Exchange Market - Industry Analysis
    • 3.1 Therapeutic Plasma Exchange Market: Market Dynamics
    • 3.2 Market Drivers
      • 3.2.1 Therapeutic plasma exchange for pediatric patients to drive market growth
    • 3.3 Market Restraints
      • 3.3.1. High cost of for therapeutic plasma exchange products to hinder the market growth
    • 3.4 Market Opportunities
      • 3.4.1. Continuous advancement to present market growth opportunities
    • 3.5 Market Challenges
    • 3.6 Porter’s Five Forces Analysis
    • 3.7 Market Attractiveness Analysis
      • 3.7.1 Market attractiveness analysis By Diseases Indication
      • 3.7.2 Market attractiveness analysis By End-Users
  • Chapter 4. Global Therapeutic Plasma Exchange Market- Competitive Landscape
    • 4.1 Company market share analysis
      • 4.1.1 Global Therapeutic Plasma Exchange Market: company market share, 2021
    • 4.2 Strategic development
      • 4.2.1 Acquisitions & mergers
      • 4.2.2 New Product launches
      • 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4 Research and development and Regional expansion
    • 4.3 Price trend analysis
  • Chapter 5. Global Therapeutic Plasma Exchange Market - Diseases Indication Analysis
    • 5.1 Global Therapeutic Plasma Exchange Market overview: By Diseases Indication
      • 5.1.1 Global Therapeutic Plasma Exchange Market share, By Diseases Indication, 2021 and 2028
    • 5.2 Neurological Disorders
      • 5.2.1 Global Therapeutic Plasma Exchange Market by Neurological Disorders, 2022 - 2028 (USD Million)
    • 5.3 Renal Disorders
      • 5.3.1 Global Therapeutic Plasma Exchange Market by Renal Disorders, 2022 - 2028 (USD Million)
    • 5.4 Hematology Disorders
      • 5.4.1 Global Therapeutic Plasma Exchange Market by Hematology Disorders, 2022 - 2028 (USD Million)
  • Chapter 6. Global Therapeutic Plasma Exchange Market - End-Users Analysis
    • 6.1 Global Therapeutic Plasma Exchange Market overview: By End-Users
      • 6.1.1 Global Therapeutic Plasma Exchange Market share, By End-Users, 2021 and 2028
    • 6.2 Hospitals
      • 6.2.1 Global Therapeutic Plasma Exchange Market by Hospitals, 2022 - 2028 (USD Million)
    • 6.3 Specialty Clinics
      • 6.3.1 Global Therapeutic Plasma Exchange Market by Specialty Clinics, 2022 - 2028 (USD Million)
    • 6.4 Ambulatory Surgical Centers
      • 6.4.1 Global Therapeutic Plasma Exchange Market by Ambulatory Surgical Centers, 2022 - 2028 (USD Million)
  • Chapter 7. Therapeutic Plasma Exchange Market - Regional Analysis
    • 7.1 Global Therapeutic Plasma Exchange Market Regional Overview
    • 7.2 Global Therapeutic Plasma Exchange Market Share, by Region, 2021 & 2028 (USD Million)
    • 7.3. North America
      • 7.3.1 North America Therapeutic Plasma Exchange Market, 2022 - 2028 (USD Million)
        • 7.3.1.1 North America Therapeutic Plasma Exchange Market, by Country, 2022 - 2028 (USD Million)
    • 7.4 North America Therapeutic Plasma Exchange Market, by Diseases Indication, 2022 - 2028
      • 7.4.1 North America Therapeutic Plasma Exchange Market, by Diseases Indication, 2022 - 2028 (USD Million)
    • 7.5 North America Therapeutic Plasma Exchange Market, by End-Users, 2022 - 2028
      • 7.5.1 North America Therapeutic Plasma Exchange Market, by End-Users, 2022 - 2028 (USD Million)
    • 7.4. Europe
      • 7.4.2 Europe Therapeutic Plasma Exchange Market, 2022 - 2028 (USD Million)
        • 7.4.2.1 Europe Therapeutic Plasma Exchange Market, by Country, 2022 - 2028 (USD Million)
    • 7.4 Europe Therapeutic Plasma Exchange Market, by Diseases Indication, 2022 - 2028
      • 7.4.1 Europe Therapeutic Plasma Exchange Market, by Diseases Indication, 2022 - 2028 (USD Million)
    • 7.5 Europe Therapeutic Plasma Exchange Market, by End-Users, 2022 - 2028
      • 7.5.1 Europe Therapeutic Plasma Exchange Market, by End-Users, 2022 - 2028 (USD Million)
    • 7.5. Asia Pacific
      • 7.5.3 Asia Pacific Therapeutic Plasma Exchange Market, 2022 - 2028 (USD Million)
        • 7.5.3.1 Asia Pacific Therapeutic Plasma Exchange Market, by Country, 2022 - 2028 (USD Million)
    • 7.4 Asia Pacific Therapeutic Plasma Exchange Market, by Diseases Indication, 2022 - 2028
      • 7.4.1 Asia Pacific Therapeutic Plasma Exchange Market, by Diseases Indication, 2022 - 2028 (USD Million)
    • 7.5 Asia Pacific Therapeutic Plasma Exchange Market, by End-Users, 2022 - 2028
      • 7.5.1 Asia Pacific Therapeutic Plasma Exchange Market, by End-Users, 2022 - 2028 (USD Million)
    • 7.6. Latin America
      • 7.6.4 Latin America Therapeutic Plasma Exchange Market, 2022 - 2028 (USD Million)
        • 7.6.4.1 Latin America Therapeutic Plasma Exchange Market, by Country, 2022 - 2028 (USD Million)
    • 7.4 Latin America Therapeutic Plasma Exchange Market, by Diseases Indication, 2022 - 2028
      • 7.4.1 Latin America Therapeutic Plasma Exchange Market, by Diseases Indication, 2022 - 2028 (USD Million)
    • 7.5 Latin America Therapeutic Plasma Exchange Market, by End-Users, 2022 - 2028
      • 7.5.1 Latin America Therapeutic Plasma Exchange Market, by End-Users, 2022 - 2028 (USD Million)
    • 7.7. The Middle-East and Africa
      • 7.7.5 The Middle-East and Africa Therapeutic Plasma Exchange Market, 2022 - 2028 (USD Million)
        • 7.7.5.1 The Middle-East and Africa Therapeutic Plasma Exchange Market, by Country, 2022 - 2028 (USD Million)
    • 7.4 The Middle-East and Africa Therapeutic Plasma Exchange Market, by Diseases Indication, 2022 - 2028
      • 7.4.1 The Middle-East and Africa Therapeutic Plasma Exchange Market, by Diseases Indication, 2022 - 2028 (USD Million)
    • 7.5 The Middle-East and Africa Therapeutic Plasma Exchange Market, by End-Users, 2022 - 2028
      • 7.5.1 The Middle-East and Africa Therapeutic Plasma Exchange Market, by End-Users, 2022 - 2028 (USD Million)
  • Chapter 8. Company Profiles
    • 8.1 Asahi Kasei Corporation
      • 8.1.1 Overview
      • 8.1.2 Financials
      • 8.1.3 Product Portfolio
      • 8.1.4 Business Strategy
      • 8.1.5 Recent Developments
    • 8.2 Baxter International Inc.
      • 8.2.1 Overview
      • 8.2.2 Financials
      • 8.2.3 Product Portfolio
      • 8.2.4 Business Strategy
      • 8.2.5 Recent Developments
    • 8.3 Terumo Corporation
      • 8.3.1 Overview
      • 8.3.2 Financials
      • 8.3.3 Product Portfolio
      • 8.3.4 Business Strategy
      • 8.3.5 Recent Developments
    • 8.4 B. Braun Melungeon AG
      • 8.4.1 Overview
      • 8.4.2 Financials
      • 8.4.3 Product Portfolio
      • 8.4.4 Business Strategy
      • 8.4.5 Recent Developments
    • 8.5 Fresenius Kabir AG
      • 8.5.1 Overview
      • 8.5.2 Financials
      • 8.5.3 Product Portfolio
      • 8.5.4 Business Strategy
      • 8.5.5 Recent Developments
    • 8.6 Karasumi Laboratories Inc.
      • 8.6.1 Overview
      • 8.6.2 Financials
      • 8.6.3 Product Portfolio
      • 8.6.4 Business Strategy
      • 8.6.5 Recent Developments
    • 8.7 Haemon tics Corporation
      • 8.7.1 Overview
      • 8.7.2 Financials
      • 8.7.3 Product Portfolio
      • 8.7.4 Business Strategy
      • 8.7.5 Recent Developments
    • 8.8 Ceros Corporation
      • 8.8.1 Overview
      • 8.8.2 Financials
      • 8.8.3 Product Portfolio
      • 8.8.4 Business Strategy
      • 8.8.5 Recent Developments
    • 8.9 Hema care Corporation
      • 8.9.1 Overview
      • 8.9.2 Financials
      • 8.9.3 Product Portfolio
      • 8.9.4 Business Strategy
      • 8.9.5 Recent Developments
    • 8.10 Medica S.p.A.
      • 8.10.1 Overview
      • 8.10.2 Financials
      • 8.10.3 Product Portfolio
      • 8.10.4 Business Strategy
      • 8.10.5 Recent Developments

Table Of Figures

  • 1. Market research Type
  • 2. Market research methodology
  • 3. Global Therapeutic Plasma Exchange Market, 2022 - 2028 (USD Million)
  • 4. Porter’s Five Forces Analysis
  • 5. Global Therapeutic Plasma Exchange Market attractiveness, By Diseases Indication
  • 6. Global Therapeutic Plasma Exchange Market attractiveness, By End-Users
  • 7. Global Therapeutic Plasma Exchange Market share by Diseases Indication, 2022 and 2028 (USD Million)
  • 8. Global Therapeutic Plasma Exchange Market by Neurological Disorders, 2022 - 2028 (USD Million)
  • 9. Global Therapeutic Plasma Exchange Market by Renal Disorders, 2022 - 2028 (USD Million)
  • 10. Global Therapeutic Plasma Exchange Market by Hematology Disorders, 2022 - 2028 (USD Million)
  • 11. Global Therapeutic Plasma Exchange Market share by End-Users, 2022 and 2028 (USD Million)
  • 12. Global Therapeutic Plasma Exchange Market by Hospitals, 2022 - 2028 (USD Million)
  • 13. Global Therapeutic Plasma Exchange Market by Specialty Clinics, 2022 - 2028 (USD Million)
  • 14. Global Therapeutic Plasma Exchange Market by Ambulatory Surgical Centers, 2022 - 2028 (USD Million)
  • 15. Global Therapeutic Plasma Exchange Market share, by Region, 2022 and 2028
  • 16. North America Therapeutic Plasma Exchange Market, 2022 - 2028 (USD Million)
  • 17. Europe Therapeutic Plasma Exchange Market, 2022 - 2028 (USD Million)
  • 18. Asia Pacific Therapeutic Plasma Exchange Market, 2022 - 2028 (USD Million)
  • 19. Latin America Therapeutic Plasma Exchange Market, 2022 - 2028 (USD Million)
  • 20. The Middle-East and Africa Therapeutic Plasma Exchange Market, 2022 - 2028 (USD Million)

Table Of Tables

  • 1. Global Therapeutic Plasma Exchange Market: Snapshot
  • 2. Drivers of the Therapeutic Plasma Exchange Market: impact analysis
  • 3. North America Therapeutic Plasma Exchange Market revenue, By Diseases Indication, 2022 - 2028 (USD Million)
  • 4. North America Therapeutic Plasma Exchange Market revenue, By End-Users, 2022 - 2028 (USD Million)
  • 5. U.S. Therapeutic Plasma Exchange Market revenue, By Diseases Indication, 2022 - 2028 (USD Million)
  • 6. U.S. Therapeutic Plasma Exchange Market revenue, By End-Users, 2022 - 2028 (USD Million)
  • 7. Canada Therapeutic Plasma Exchange Market revenue, By Diseases Indication, 2022 - 2028 (USD Million)
  • 8. Canada Therapeutic Plasma Exchange Market revenue, By End-Users, 2022 - 2028 (USD Million)
  • 9. Europe Therapeutic Plasma Exchange Market revenue, By Diseases Indication, 2022 - 2028 (USD Million)
  • 10. Europe Therapeutic Plasma Exchange Market revenue, By End-Users, 2022 - 2028 (USD Million)
  • 11. Germany Therapeutic Plasma Exchange Market revenue, By Diseases Indication, 2022 - 2028 (USD Million)
  • 12. Germany Therapeutic Plasma Exchange Market revenue, By End-Users, 2022 - 2028 (USD Million)
  • 13. France Therapeutic Plasma Exchange Market revenue, By Diseases Indication, 2022 - 2028 (USD Million)
  • 14. France Therapeutic Plasma Exchange Market revenue, By End-Users, 2022 - 2028 (USD Million)
  • 15. U.K. Therapeutic Plasma Exchange Market revenue, By Diseases Indication, 2022 - 2028 (USD Million)
  • 16. U.K. Therapeutic Plasma Exchange Market revenue, By End-Users, 2022 - 2028 (USD Million)
  • 17. Italy Therapeutic Plasma Exchange Market revenue, By Diseases Indication, 2022 - 2028 (USD Million)
  • 18. Italy Therapeutic Plasma Exchange Market revenue, By End-Users, 2022 - 2028 (USD Million)
  • 19. Spain Therapeutic Plasma Exchange Market revenue, By Diseases Indication, 2022 - 2028 (USD Million)
  • 20. Spain Therapeutic Plasma Exchange Market revenue, By End-Users, 2022 - 2028 (USD Million)
  • 21. Rest of Europe Therapeutic Plasma Exchange Market revenue, By Diseases Indication, 2022 - 2028 (USD Million)
  • 22. Rest of Europe Therapeutic Plasma Exchange Market revenue, By End-Users, 2022 - 2028 (USD Million)
  • 23. Asia Pacific Therapeutic Plasma Exchange Market revenue, By Diseases Indication, 2022 - 2028 (USD Million)
  • 24. Asia Pacific Therapeutic Plasma Exchange Market revenue, By End-Users, 2022 - 2028 (USD Million)
  • 25. China Therapeutic Plasma Exchange Market revenue, By Diseases Indication, 2022 - 2028 (USD Million)
  • 26. China Therapeutic Plasma Exchange Market revenue, By End-Users, 2022 - 2028 (USD Million)
  • 27. Japan Therapeutic Plasma Exchange Market revenue, By Diseases Indication, 2022 - 2028 (USD Million)
  • 28. Japan Therapeutic Plasma Exchange Market revenue, By End-Users, 2022 - 2028 (USD Million)
  • 29. India Therapeutic Plasma Exchange Market revenue, By Diseases Indication, 2022 - 2028 (USD Million)
  • 30. India Therapeutic Plasma Exchange Market revenue, By End-Users, 2022 - 2028 (USD Million)
  • 31. South Korea Therapeutic Plasma Exchange Market revenue, By Diseases Indication, 2022 - 2028 (USD Million)
  • 32. South Korea Therapeutic Plasma Exchange Market revenue, By End-Users, 2022 - 2028 (USD Million)
  • 33. South-East Asia Therapeutic Plasma Exchange Market revenue, By Diseases Indication, 2022 - 2028 (USD Million)
  • 34. South-East Asia Therapeutic Plasma Exchange Market revenue, By End-Users, 2022 - 2028 (USD Million)
  • 35. Rest of Asia Pacific Therapeutic Plasma Exchange Market revenue, By Diseases Indication, 2022 - 2028 (USD Million)
  • 36. Rest of Asia Pacific Therapeutic Plasma Exchange Market revenue, By End-Users, 2022 - 2028 (USD Million)
  • 37. Latin America Therapeutic Plasma Exchange Market revenue, By Diseases Indication, 2022 - 2028 (USD Million)
  • 38. Latin America Therapeutic Plasma Exchange Market revenue, By End-Users, 2022 - 2028 (USD Million)
  • 39. Brazil Therapeutic Plasma Exchange Market revenue, By Diseases Indication, 2022 - 2028 (USD Million)
  • 40. Brazil Therapeutic Plasma Exchange Market revenue, By End-Users, 2022 - 2028 (USD Million)
  • 41. Mexico Therapeutic Plasma Exchange Market revenue, By Diseases Indication, 2022 - 2028 (USD Million)
  • 42. Mexico Therapeutic Plasma Exchange Market revenue, By End-Users, 2022 - 2028 (USD Million)
  • 43. Rest of Latin America Therapeutic Plasma Exchange Market revenue, By Diseases Indication, 2022 - 2028 (USD Million)
  • 44. Rest of Latin America Therapeutic Plasma Exchange Market revenue, By End-Users, 2022 - 2028 (USD Million)
  • 45. The Middle-East and Africa Therapeutic Plasma Exchange Market revenue, By Diseases Indication, 2022 - 2028 (USD Million)
  • 46. The Middle-East and Africa Therapeutic Plasma Exchange Market revenue, By End-Users, 2022 - 2028 (USD Million)
  • 47. GCC Countries Therapeutic Plasma Exchange Market revenue, By Diseases Indication, 2022 - 2028 (USD Million)
  • 48. GCC Countries Therapeutic Plasma Exchange Market revenue, By End-Users, 2022 - 2028 (USD Million)
  • 49. South Africa Therapeutic Plasma Exchange Market revenue, By Diseases Indication, 2022 - 2028 (USD Million)
  • 50. South Africa Therapeutic Plasma Exchange Market revenue, By End-Users, 2022 - 2028 (USD Million)
  • 51. Rest of Middle-East Africa Therapeutic Plasma Exchange Market revenue, By Diseases Indication, 2022 - 2028 (USD Million)
  • 52. Rest of Middle-East Africa Therapeutic Plasma Exchange Market revenue, By End-Users, 2022 - 2028 (USD Million)

Methodology

Choose License Type

FrequentlyAsked Questions

The chronic disease prevalence and aging population will contribute to the global market expansion for therapeutic plasma exchange. An increase in healthcare spending will further boost the global market for therapeutic plasma exchange.

According to the report, the global therapeutic plasma exchange market was worth USD 1,528.40 million in 2021 and is estimated to grow to USD 2306.60 million by 2028, with a compound annual growth rate (CAGR) of approximately 7.10 percent over the forecast period.

North America is anticipated to continue leading the therapeutic plasma exchange market throughout the projected period. The prevalence and incidence of neurological diseases are increasing in the elderly population, knowledge of the use of plasma exchange in the therapy of neurodegenerative disorders is rising, and key companies are increasing their R&D expenditures on new applications for therapeutic plasma exchange in the management of neurological disorders.

Some of the main competitors dominating the global therapeutic plasma exchange market include - Asahi Kasei Corporation, Baxter International, Inc., Terumo Corporation, B. Braun Melungeon AG, Fresenius Kabir AG, Karasumi Laboratories, Inc., Haemon tics Corporation, Ceros Corporation, Hema care Corporation, and Medica S.p.A.

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • paypal
  • amazon
  • visa
  • master card

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed